SEPTEMBER 15, 2016 | The most significant change to the newly published IAC Standards and Guidelines for Nuclear/PET Accreditation is the inclusion of administered dose ranges, which have been added to the Standards in an effort to reduce patient radiation exposure in myocardial perfusion imaging studies.
Recently published research1,2 demonstrates that adherence to clinical nuclear imaging guidelines for reduced patient radiation exposure is rarely implemented, resulting in administration of higher doses than necessary for some patients undergoing myocardial perfusion studies. Upon review of this research, the IAC Nuclear/PET Board of Directors has made the decision to include specific administered dose ranges within the IAC Standards and Guidelines for Nuclear/PET Accreditation, in an effort to focus facilities’ awareness on the patient dose they are administering. The associated revision to the Standards includes publication of the chart published by the American Society of Nuclear Cardiology, entitled Current SPECT Myocardial Perfusion Imaging Protocols: Required Radiopharmaceutical Activities and Their Corresponding Radiation Effective Doses, with the ultimate goal of ensuring that the lowest radiation dose is administered to provide optimal imaging results for patients referred for myocardial perfusion imaging studies.
In accordance with the IAC’s mission of Improving health care through accreditation®, the IAC Nuclear/PET Board of Directors has made the decision to mandate specific dose ranges to decrease radiation exposure, thus ensuring patient safety.